These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17195092)

  • 1. CD95 tyrosine phosphorylation is required for CD95 oligomerization.
    Eberle A; Reinehr R; Becker S; Keitel V; Häussinger D
    Apoptosis; 2007 Apr; 12(4):719-29. PubMed ID: 17195092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells.
    Eberle A; Reinehr R; Becker S; Häussinger D
    Hepatology; 2005 Feb; 41(2):315-26. PubMed ID: 15660394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperosmotic activation of the CD95 system.
    Reinehr R; Häussinger D
    Methods Enzymol; 2007; 428():145-60. PubMed ID: 17875416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells.
    Reinehr R; Sommerfeld A; Häussinger D
    Gastroenterology; 2008 May; 134(5):1494-506. PubMed ID: 18471522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD95 activation in the liver: ion fluxes and oxidative signaling.
    Reinehr R; Häussinger D
    Arch Biochem Biophys; 2007 Jun; 462(2):124-31. PubMed ID: 17258167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A FRET-based probe for epidermal growth factor receptor bound non-covalently to a pair of synthetic amphipathic helixes.
    Itoh RE; Kurokawa K; Fujioka A; Sharma A; Mayer BJ; Matsuda M
    Exp Cell Res; 2005 Jul; 307(1):142-52. PubMed ID: 15922734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperosmotic activation of the CD95 death receptor system.
    Reinehr R; Häussinger D
    Acta Physiol (Oxf); 2006; 187(1-2):199-203. PubMed ID: 16734756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile salt-induced apoptosis involves NADPH oxidase isoform activation.
    Reinehr R; Becker S; Keitel V; Eberle A; Grether-Beck S; Häussinger D
    Gastroenterology; 2005 Dec; 129(6):2009-31. PubMed ID: 16344068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperosmolarity and CD95L trigger CD95/EGF receptor association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation.
    Reinehr R; Schliess F; Häussinger D
    FASEB J; 2003 Apr; 17(6):731-3. PubMed ID: 12586732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibition blocks ligand-induced dynamic processing and internalization of epidermal growth factor receptor via altered receptor ubiquitination and phosphorylation.
    Kesarwala AH; Samrakandi MM; Piwnica-Worms D
    Cancer Res; 2009 Feb; 69(3):976-83. PubMed ID: 19176375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
    Takeuchi K; Shin-ya T; Nishio K; Ito F
    FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95-tyrosine nitration inhibits hyperosmotic and CD95 ligand-induced CD95 activation in rat hepatocytes.
    Reinehr R; Görg B; Höngen A; Häussinger D
    J Biol Chem; 2004 Mar; 279(11):10364-73. PubMed ID: 14679192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of EGF-induced tyrosine phosphorylation of reggie-1/flotillin-2 in cell spreading and signaling to the actin cytoskeleton.
    Neumann-Giesen C; Fernow I; Amaddii M; Tikkanen R
    J Cell Sci; 2007 Feb; 120(Pt 3):395-406. PubMed ID: 17213334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor induces changes of interaction between epidermal growth factor receptor and actin in intact cells.
    Song W; Xuan H; Lin Q
    Acta Biochim Biophys Sin (Shanghai); 2008 Aug; 40(8):754-60. PubMed ID: 18685792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance of activated EGFR higher-order oligomers on the cell surface.
    Clayton AH; Orchard SG; Nice EC; Posner RG; Burgess AW
    Growth Factors; 2008 Dec; 26(6):316-24. PubMed ID: 18937111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo.
    Adams TE; Koziolek EJ; Hoyne PH; Bentley JD; Lu L; Lovrecz G; Ward CW; Lee FT; Scott AM; Nash AD; Rothacker J; Nice EC; Burgess AW; Johns TG
    Growth Factors; 2009 Jun; 27(3):141-54. PubMed ID: 19333814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.
    Murillo-Carretero M; Torroglosa A; Castro C; Villalobo A; Estrada C
    Free Radic Biol Med; 2009 Feb; 46(4):471-9. PubMed ID: 19056486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells.
    Kozer N; Henderson C; Jackson JT; Nice EC; Burgess AW; Clayton AH
    Phys Biol; 2011 Dec; 8(6):066002. PubMed ID: 21946082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
    Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor signaling in liver cell proliferation and apoptosis.
    Reinehr R; Häussinger D
    Biol Chem; 2009 Oct; 390(10):1033-7. PubMed ID: 19558330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.